CD14 CHO Recombinant Cell Line

Catalog #
78335
$7,150 *
Size: 2 vials
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

Recombinant clonal CHO stable cell line constitutively expressing full length human CD14 protein.  The surface expression of CD14 in this cell line was validated by flow cytometry.

Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.

Synonyms
Monocyte differentiation antigen CD14, CD_antigen CD14
Product Info
Storage and Usage
Citations
Host Cell Line
CHO-K1 cells, Chinese Hamster Ovary, epithelial-like cells, adherent
Species
Human
Supplied As
Each vial contains 2 x 106 cells in 1 ml of 10% DMSO in FBS
Materials Required But Not Supplied

Materials Required for Cell Culture

Name Ordering Information
Thaw Medium 3 BPS Bioscience #60186
Growth Medium 3D BPS Bioscience #79539
UniProt #
P08571
Mycoplasma Testing

The cell line has been screened using the MycoAlert™ Mycoplasma Detection kit (Lonza, #LT07-218) to confirm the absence of Mycoplasma species.

Background

CD14 (Cluster of Differentiation-14) is a surface antigen expressed predominantly by monocytes & macrophages.  It is considered a patterned recognition receptor (PRR), which recognizes pathogen markers.  Specifically, CD14 acts as a co-receptor for lipopolysaccharides (LPS) found in the outer membrane of gram-negative bacteria. Through this interaction, CD14 supports initiation of the innate immune response during bacterial infection.  CD14 has also been found to contribute toward immune responses to viral pathogens such as human respiratory syncytial virus (RSV), and may amplify the inflammatory response observed in severe cases of SARS-CoV-2 infection (COVID-19).  Monoclonal antibodies against CD14 are currently undergoing clinical trial as a candidate treatment to limit severe inflammatory responses common in patients hospitalized with COVID-19